Lung Master Protocol (Lung-MAP)—A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400-Reference-Cited by-同舟云学术

Lung Master Protocol (Lung-MAP)—A Biomarker-Driven Protocol for Accelerating Development of Therapies for Squamous Cell Lung Cancer: SWOG S1400

Published:2015-02-13 Issue:7 Volume:21 Page:1514-1524
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Herbst Roy S.,Gandara David R.,Hirsch Fred R.,Redman Mary W.,LeBlanc Michael,Mack Philip C.,Schwartz Lawrence H.,Vokes Everett,Ramalingam Suresh S.,Bradley Jeffrey D.,Sparks Dana,Zhou Yang,Miwa Crystal,Miller Vincent A.,Yelensky Roman,Li Yali,Allen Jeff D.,Sigal Ellen V.,Wholley David,Sigman Caroline C.,Blumenthal Gideon M.,Malik Shakun,Kelloff Gary J.,Abrams Jeffrey S.,Blanke Charles D.,Papadimitrakopoulou Vassiliki A.

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 206 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Lung-MAP Next-Generation Sequencing Analysis of Advanced Squamous Cell Lung Cancers (SWOG S1400);Journal of Thoracic Oncology;2024-08

2. Leveraging machine learning: Covariate-adjusted Bayesian adaptive randomization and subgroup discovery in multi-arm survival trials;Contemporary Clinical Trials;2024-07

3. A process to reanalyze clinical DNA sequencing data for biomarker matching in the Lung-MAP Master Protocol;The Oncologist;2024-04-10

4. Advancing randomized controlled trial methodologies: The place of innovative trial design in eating disorders research;International Journal of Eating Disorders;2024-03-12

5. Cost-effectiveness of immunotherapies for advanced squamous non-small cell lung cancer: a systematic review;BMC Cancer;2024-03-06